Prostate cancer research and the National Cancer Institute

Otis Brawley, N. Figueroa-Valles

Research output: Contribution to journalReview article

Abstract

The National Cancer Institute (NCI) is the largest funder of prostate cancer research in the United States and indeed the world. It is sponsoring a number of studies to answer the significant questions pertinent to prostate cancer and pertinent to black men. These include studies of epidemiology; cancer prevention, screening, and control; clinical treatment; and basic science. In addition, the NCI is charged with dissemination of research findings to physicians and the lay public. The following is a description of the NCI prostate cancer research portfolio including the scientific questions being addressed and how are they being addressed.

Original languageEnglish (US)
Pages (from-to)235-240
Number of pages6
JournalSeminars in Urologic Oncology
Volume16
Issue number4
StatePublished - Dec 16 1998
Externally publishedYes

Fingerprint

National Cancer Institute (U.S.)
Prostatic Neoplasms
Research
Early Detection of Cancer
Epidemiology
Physicians
Therapeutics

Keywords

  • Basic cancer research
  • Clinical trial
  • National Cancer Institute
  • Prostate neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Prostate cancer research and the National Cancer Institute. / Brawley, Otis; Figueroa-Valles, N.

In: Seminars in Urologic Oncology, Vol. 16, No. 4, 16.12.1998, p. 235-240.

Research output: Contribution to journalReview article

Brawley, Otis ; Figueroa-Valles, N. / Prostate cancer research and the National Cancer Institute. In: Seminars in Urologic Oncology. 1998 ; Vol. 16, No. 4. pp. 235-240.
@article{28f39e4bd84a4c43af4034b9fcc80cc4,
title = "Prostate cancer research and the National Cancer Institute",
abstract = "The National Cancer Institute (NCI) is the largest funder of prostate cancer research in the United States and indeed the world. It is sponsoring a number of studies to answer the significant questions pertinent to prostate cancer and pertinent to black men. These include studies of epidemiology; cancer prevention, screening, and control; clinical treatment; and basic science. In addition, the NCI is charged with dissemination of research findings to physicians and the lay public. The following is a description of the NCI prostate cancer research portfolio including the scientific questions being addressed and how are they being addressed.",
keywords = "Basic cancer research, Clinical trial, National Cancer Institute, Prostate neoplasms",
author = "Otis Brawley and N. Figueroa-Valles",
year = "1998",
month = "12",
day = "16",
language = "English (US)",
volume = "16",
pages = "235--240",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Prostate cancer research and the National Cancer Institute

AU - Brawley, Otis

AU - Figueroa-Valles, N.

PY - 1998/12/16

Y1 - 1998/12/16

N2 - The National Cancer Institute (NCI) is the largest funder of prostate cancer research in the United States and indeed the world. It is sponsoring a number of studies to answer the significant questions pertinent to prostate cancer and pertinent to black men. These include studies of epidemiology; cancer prevention, screening, and control; clinical treatment; and basic science. In addition, the NCI is charged with dissemination of research findings to physicians and the lay public. The following is a description of the NCI prostate cancer research portfolio including the scientific questions being addressed and how are they being addressed.

AB - The National Cancer Institute (NCI) is the largest funder of prostate cancer research in the United States and indeed the world. It is sponsoring a number of studies to answer the significant questions pertinent to prostate cancer and pertinent to black men. These include studies of epidemiology; cancer prevention, screening, and control; clinical treatment; and basic science. In addition, the NCI is charged with dissemination of research findings to physicians and the lay public. The following is a description of the NCI prostate cancer research portfolio including the scientific questions being addressed and how are they being addressed.

KW - Basic cancer research

KW - Clinical trial

KW - National Cancer Institute

KW - Prostate neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0031788556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031788556&partnerID=8YFLogxK

M3 - Review article

VL - 16

SP - 235

EP - 240

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 4

ER -